Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02192112
Other study ID # NUVA.NV1301
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 2014
Est. completion date May 8, 2018

Study information

Verified date August 2018
Source NuVasive
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Though the utility of NVM5 neuromonitoring by stimulating within the surgical site during XLIF has been demonstrated, it is hypothesized that more information may be gathered if a greater section of the motor neural pathway was monitored (i.e., stimulation above the surgical site and recording the subsequent muscle response in the lower limbs). Currently, there has not been demonstrated a practical method of stimulating the lumbosacral nerve roots locally, but well-above the surgical site in this fashion.

This protocol is intended to evaluate the feasibility and reproducibility of using surface stimulation and return (anode) electrodes to stimulate the lumbosacral nerve roots, and record responses from the relevant innervated muscle groups of the lower limbs.


Recruitment information / eligibility

Status Completed
Enrollment 57
Est. completion date May 8, 2018
Est. primary completion date May 8, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Male and female spine surgery patients who are at least 18 years of age

2. Surgical candidates for lateral approach lumbar spine surgery at spinal levels L2 to L5, inclusive of L4-5

3. Patients who understand the conditions of enrollment and are willing to sign an informed consent to participate in the evaluation

Exclusion Criteria:

1. Currently undergoing surgical treatment at any spinal level other than L2 to L5, including S1

2. Pregnant women

3. Implanted pacemaker, defibrillator, or other electronic devices

4. Involved in active litigation relating to the spine (worker's compensation claim is allowed if it is not contested)

5. Underlying neurological disease or neurological deficit that is not associated with the condition for which he/she is seeking surgical intervention (e.g., diabetic peripheral neuropathy)

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Durango Orthopaedics Associates/Spine Colorado Durango Colorado
United States Pinnacle Orthopaedics & Sports Medicine Specialists Marietta Georgia

Sponsors (1)

Lead Sponsor Collaborator
NuVasive

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Reproducibility of obtaining reliable responses and response thresholds monitored over the course of surgery. Intraoperative
Secondary Correlation of any observed changes in the response or response thresholds with surgical events. Intraoperative
Secondary Correlation between patient characteristics and the ability to generate and reliably record responses and response thresholds. Intraoperative
Secondary Correlation between observed changes in the response or response threshold and postoperative neural status. 6 weeks postoperative
See also
  Status Clinical Trial Phase
Completed NCT00405600 - Spine Fusion Instrumented With BMP-2 vs Uninstrumented With Infuse BMP-2 Alone N/A
Completed NCT02272140 - Advanced XLIF Monitoring Multicenter Study
Completed NCT00493558 - Spine Research With Roentgen Stereophotogrammetric Analysis Phase 4

External Links